Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
217.00    -0.50 (-0.23%)
Bid:
215.00
Ask:
219.00
Spread: 4.00 (1.86%)
Market Cap: £147.96m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

LTIP Exercise and Total Voting Rights Update

9 Jun 2025 13:15

RNS Number : 0425M
Helios Underwriting Plc
09 June 2025
 

Helios Underwriting plc

9 June 2025

 

Helios Underwriting plc

("Helios", the "Company" or the "Group")

PDMR Dealing - LTIP Exercise and Total Voting Rights Update

Helios, the only publicly traded company offering instant access to a diverse portfolio of syndicates at Lloyd's of London, announces that on 9 June 2025 its Chief Operating Officer, Mr Adhiraj Maitra (person discharging managerial responsibilities) exercised a vested nil cost option held under the Helios Underwriting plc Long Term Incentive Plan over 70,000 ordinary shares of 10 pence each ("Ordinary Shares") in the Company.

The option (a buy-out recruitment related award) was granted on 27 September 2024 and became exercisable from 5 March 2025.

The exercise of the option is settled in part by the transfer of 37,100 Ordinary Shares issued from the Company's treasury account to Mr Maitra and in part with a cash payment equal to the market value of 32,900 Ordinary Shares to meet Mr Maitra's liability to income tax and employee national insurance arising on the exercise of the option.

Following the transaction, Mr Maitra has a beneficial holding of 37,100 Ordinary Shares which represents 0.0475% of the current issued share capital.

Following the transaction, the Company's issued ordinary share capital consists of 78,110,302 Ordinary Shares of which a total of 5,630,255 Ordinary Shares are held in treasury. Therefore, the total number of Ordinary Shares with voting rights in Helios Underwriting plc is 72,480,047.

The above figure of 72,480,047 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

The information set out below is provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation and AIM Rule 17.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Adhiraj Maitra

2

Reason for Notification

a)

Position/status

1. Chief Operating Officer

 

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Helios Underwriting plc

b)

LEI

213800FX86DJW5TCM864

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10 pence each

ISIN - GB00B23XLS45

b)

Nature of the transaction

Exercise of option over Ordinary Shares under the Helios Underwriting plc Long Term Incentive Plan and related acquisition of Ordinary Shares of 10 pence each in Helios Underwriting plc (or, as to 47% of the vested shares, cash in lieu of such shares).

 

 

c)

Price(s) and volume(s)

 

 

 

 

Price(s)

Volume(s)

1. Nil

 

 

70,000

 

(settled by the transfer of 37,100 Ordinary Shares and in part with a cash payment equal to the market value of 32,900 shares)

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable - single transaction

Nil

e)

Date of the transaction

9 June 2025

f)

Place of the transaction

Outside of a trading venue

 

For further information please contact:

Helios Underwriting plc

John Chambers - Interim Executive Chairman

Arthur Manners - Chief Financial Officer

44 (0)203 965 6441

Deutsche Numis (Nomad and Broker)

Giles Rolls / Charles Farquhar +44 (0)20 7260 1000

 

FTI Consulting

Ed Berry +44 (0)7703 330 199

Nathan Hambrook-Skinner +44 (0)7977 817 092

Christian Harte +44 (0)7974 288 763

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market. The portfolio provides a broad spread of business primarily participating in the US and other international wholesale and reinsurance markets. For further information please visit www.huwplc.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSSAFEUEISESM
Date   Source Headline
6th Jul 20267:00 amRNSTransaction in Own Shares
3rd Jul 20267:11 amRNSResults of Scrip Dividend Election
1st Jul 20263:27 pmRNSTotal Voting Rights
29th Jun 20267:00 amRNSTransaction in Own Shares
25th Jun 20267:00 amRNSNet Asset Value Update - Q1 2026
22nd Jun 20263:59 pmRNSResults of Annual General Meeting
22nd Jun 20269:00 amRNSTransaction in Own Shares
15th Jun 20269:00 amRNSTransaction in Own Shares
12th Jun 20267:00 amRNSScrip Dividend Reference Price
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20264:05 pmRNSGrant of LTIP Award
5th Jun 20267:00 amRNSGrant of LTIP Awards
1st Jun 20267:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSNotice of AGM
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSFinal Results for the year ended 31 December 2025
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTR-1 announcement
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
27th Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTR-1: Acquisition of Voting Rights
21st Apr 20267:00 amRNSChange of Nominated Adviser
20th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20265:17 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSQuarterly Syndicate Mid-point Forecast update
20th Jan 20267:00 amRNS2026 YOA Portfolio Update
9th Jan 20267:00 amRNSAppointment of Chief Underwriting Officer
4th Dec 20255:42 pmRNSGrant of LTIP Awards
2nd Dec 20257:00 amRNSNet Asset Value(s)
13th Nov 20251:32 pmRNSDirector/PDMR Shareholding
13th Nov 20251:30 pmRNSDirector/PDMR Shareholding
7th Nov 202510:10 amRNSHolding(s) in Company
6th Nov 20251:51 pmRNSDirector/PDMR Shareholding
5th Nov 20255:48 pmRNSTR1 - Change in breakdown of voting rights
30th Oct 20257:00 amRNSResult of Tender Offer
24th Oct 202512:20 pmRNSResults of General Meeting
21st Oct 20257:01 amRNSDirector Appointments
21st Oct 20257:00 amRNSCapital Markets Day
29th Sep 20257:01 amRNSProposed Tender Offer and Notice of GM
29th Sep 20257:00 amRNSHalf Year Results
19th Sep 20257:00 amRNSAppointment of Chief Executive Officer
1st Sep 20253:37 pmRNSDirector/PDMR Shareholding
29th Aug 202512:52 pmRNSPDMR Dealing
28th Aug 20252:16 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSQuarterly Syndicate Mid-point Forecasts
1st Aug 20257:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.